Subjects: Merger/Acquisition, Proxy/Proxy Vote

Tikvah Management Announces Intention to Vote against Somalogic's Proposed Merger with Standard BioTools

Tikvah Management ("Tikvah"), a significant shareholder of Somalogic (the "Company") (Nasdaq: SLGC) with voting rights for 5.9 million shares, or 3.1% of the outstanding shares of Somalogic, today announced that it intends to vote against the Company's proposed merger with Standard BioTools Inc. (Nasdaq: LAB). Tikvah believes the proposed merger is not in the best interest of Somalogic shareholders, echoing reasons elaborated by other investors opposing the merger, including the undervaluation of Somalogic shares, an inadequate merger process and poor quality of Standard BioTool's business and balance sheet.

Tikvah reserves the right to change this intention should there be significant new developments.

News published on 22 december 2023 at 20:15 and distributed by: